Product Images Relenza

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 15 images provide visual information about the product associated with Relenza NDC 0173-0681 by Glaxosmithkline Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

zanamivir structural formula - relenza spl graphic 01

zanamivir structural formula - relenza spl graphic 01

RELENZA logo - relenza spl graphic 02

RELENZA logo - relenza spl graphic 02

This text is a description of how to use the DISKHALER device to inhale medication. It includes information on keeping the device clean, the purpose of the mouthpiece, how to advance to the next dose, how to release the medication, and the components of the device.*

Parts of the DISKHALER - relenza spl graphic 03

Parts of the DISKHALER - relenza spl graphic 03

Step A: Load the medicine in DISKHALER - relenza spl graphic 04

Step A: Load the medicine in DISKHALER - relenza spl graphic 04

Step B: Steps 1, 2, 3, and 4 - relenza spl graphic 05

Step B: Steps 1, 2, 3, and 4 - relenza spl graphic 05

Step C: Steps 1 and 2 - relenza spl graphic 06

Step C: Steps 1 and 2 - relenza spl graphic 06

Step D: Steps 1 and 2 - relenza spl graphic 07

Step D: Steps 1 and 2 - relenza spl graphic 07

Relenza carton - relenza spl graphic 08

Relenza carton - relenza spl graphic 08

relenza spl graphic 09

relenza spl graphic 09

relenza spl graphic 10

relenza spl graphic 10

relenza spl graphic 11

relenza spl graphic 11

relenza spl graphic 12

relenza spl graphic 12

relenza spl graphic 13

relenza spl graphic 13

relenza spl graphic 14

relenza spl graphic 14

relenza spl graphic 15

relenza spl graphic 15

This is a description of a medication called RELENZA, with NDC code 0173-0681-01, which is an inhalation powder containing 20mg of zanamivir. Each blister contains 5mg of zanamivir along with lactose. The medication should be used with the DISKHALER inhalation device only, and there are patient information and instructions enclosed for its use. The medication must be stored at a temperature between 15° to 30°C (59° to 86°F). It contains 5 RELANZA ROTADISKS, each with 4 blisters containing 5mg zanamivir, and one DISKHALER inhalation device. The dosage information should be obtained from the prescribing information. This medication is intended for oral inhalation only.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.